Bechini A, Riccio M, Salvati C, Bonito B, Zanella B, Biamonte M
Vaccines (Basel). 2024; 12(9).
PMID: 39340086
PMC: 11435818.
DOI: 10.3390/vaccines12091056.
Marin M, Lopez A, Melgar M, Dooling K, Curns A, Leung J
J Infect Dis. 2022; 226(Suppl 4):S407-S415.
PMID: 36265852
PMC: 10406340.
DOI: 10.1093/infdis/jiac242.
Leung J, Lopez A, Marin M
J Infect Dis. 2022; 226(Suppl 4):S400-S406.
PMID: 36265851
PMC: 10155060.
DOI: 10.1093/infdis/jiac214.
Sun X, Zhu Y, Sun H, Xu Y, Zhang L, Wang Z
Hum Vaccin Immunother. 2022; 18(6):2114255.
PMID: 35993917
PMC: 9746505.
DOI: 10.1080/21645515.2022.2114255.
Kim E, Park C, Lee G, Jeong S, Song J, Lee D
Osong Public Health Res Perspect. 2022; 13(2):133-141.
PMID: 35538685
PMC: 9091637.
DOI: 10.24171/j.phrp.2022.0087.
Impact of varicella vaccine on nosocomial outbreaks and management of post exposure prophylaxis following in a paediatric hospital.
Gentile A, Giglio N, Lucion M, Martinez A, Pejito N, Juarez M
PLoS One. 2021; 16(5):e0251496.
PMID: 34014962
PMC: 8136631.
DOI: 10.1371/journal.pone.0251496.
A Centralized Outbreak of Varicella among Children Attending Preschool in Suzhou, China.
Zhang M, Gui G, Guo F, Fan X, Zha R
Biomed Res Int. 2020; 2020:6183936.
PMID: 32462005
PMC: 7222484.
DOI: 10.1155/2020/6183936.
A persistent outbreak of varicella in a primary school in Dongguan City, Guangdong Province, China.
Zhong J, Zhang M, Huang Z, Qiu G, Rao F, Lu Z
J Int Med Res. 2019; 48(3):300060519887847.
PMID: 31771379
PMC: 7607272.
DOI: 10.1177/0300060519887847.
Literature Review on One-Dose and Two-Dose Varicella Vaccination: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
Campbell A, Ismail S, Tan B
Can Commun Dis Rep. 2019; 36(ACS-10):1-24.
PMID: 31682662
PMC: 6802437.
DOI: 10.14745/ccdr.v36i00a10.
Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
Tan B, Ismail S
Can Commun Dis Rep. 2019; 36(ACS-8):1-26.
PMID: 31682648
PMC: 6802434.
DOI: 10.14745/ccdr.v36i00a08.
Effectiveness and failure rate of the varicella vaccine in an outbreak in Jiangsu, China: a 1:2 matched case-control study.
Wang Y, Zhang L, Sun X, Cao Y, Wang Z, Liu L
Hum Vaccin Immunother. 2019; 16(3):506-512.
PMID: 31526231
PMC: 7227623.
DOI: 10.1080/21645515.2019.1665959.
[Decrease in the incidence of chickenpox in the Community of Madrid after universal childhood immunization. Years 2001-2015].
Comas L, Latasa Zamalloa P, Aleman Vega G, Ordobas Gavin M, Arce Arnaez A, Rodero Garduno I
Aten Primaria. 2017; 50(1):53-59.
PMID: 28433331
PMC: 6837086.
DOI: 10.1016/j.aprim.2017.01.010.
Varicella Vaccine Effectiveness in Preventing Community Transmission in the 2-Dose Era.
Perella D, Wang C, Civen R, Viner K, Kuguru K, Daskalaki I
Pediatrics. 2016; 137(4).
PMID: 26977081
PMC: 4887293.
DOI: 10.1542/peds.2015-2802.
Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students.
Thomas C, Shwe T, Bixler D, Del Rosario M, Grytdal S, Wang C
Pediatr Infect Dis J. 2014; 33(11):1164-8.
PMID: 24911894
PMC: 4673889.
DOI: 10.1097/INF.0000000000000444.
Varicella outbreak in a daycare: challenges and opportunities for preventing varicella outbreaks in this setting.
Daskalaki I, Thermitus R, Perella D, Viner K, Spells N, Mohanty S
Pediatr Infect Dis J. 2013; 33(4):420-2.
PMID: 24136372
PMC: 5749226.
DOI: 10.1097/INF.0000000000000127.
Impact of a routine two-dose varicella vaccination program on varicella epidemiology.
Bialek S, Perella D, Zhang J, Mascola L, Viner K, Jackson C
Pediatrics. 2013; 132(5):e1134-40.
PMID: 24101763
PMC: 4620660.
DOI: 10.1542/peds.2013-0863.
Single-dose varicella vaccine effectiveness in school settings in China.
Wang Z, Yang H, Li K, Zhang A, Feng Z, Seward J
Vaccine. 2013; 31(37):3834-8.
PMID: 23845816
PMC: 4605419.
DOI: 10.1016/j.vaccine.2013.06.075.
A varicella outbreak in a school with high one-dose vaccination coverage, Beijing, China.
Lu L, Suo L, Li J, Zhai L, Zheng Q, Pang X
Vaccine. 2012; 30(34):5094-8.
PMID: 22687763
PMC: 4620431.
DOI: 10.1016/j.vaccine.2012.05.072.
Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data.
Goldman G, King P
Vaccine. 2012; 31(13):1680-94.
PMID: 22659447
PMC: 3759842.
DOI: 10.1016/j.vaccine.2012.05.050.